FDA Sends CBD Enforcement Policy to White House
On July 22, 2020, the U.S. Food and Drug Administration sent to the White House Office of Management and Budget (OMB) for review its draft “Cannabidiol Enforcement Policy,” signaling to the industry that long-awaited federal guidance on cannabidiol (CBD) products is nearing.…
Read More